NVDA
NVIDIA
-- 135.530 TSLA
Tesla
-- 388.406 AMD
Advanced Micro Devices
-- 115.230 RGTI
Rigetti Computing
-- 9.9150 TSM
Taiwan Semiconductor
-- 207.520 
Simufilam for Alzheimer DiseasePhase-Based Progress Estimates: Phase 2 trials have some data supporting safety. Phase 3 trials have some data supporting efficacy & multiple rounds of data supporting
$Cassava Sciences (SAVA.US)$ According to Withpower Alzheimer’s trial review article.
Simufilam for Alzheimer Disease
Phase-Based Progress Estimates: Phase 2 trials have some data supporting safety. Phase 3 trials have some data supporting efficacy & multiple rounds of data supporting safety. The underlying Phase data is collected from clinical trials(dot)gov Open APi
Simufilam for Alzheimer Disease
Phase-Based Progress Estimates: Phase 2 trials have some data supporting safety. Phase 3 trials have some data supporting efficacy & multiple rounds of data supporting safety. The underlying Phase data is collected from clinical trials(dot)gov Open APi
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Discussing
Trump 2.0 countdown: What's the next big opportunity in the markets?
Trump is gearing up for a return to the political stage, and his "America First" tariff policies, along with his stance on cryptocurrency an
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day